Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Automated Manual Lymphatic Drainage Therapy to Improve Glymphatic Function in OSA Patients

NCT: NCT07301762 · ENROLLING_BY_INVITATION

NCT IDNCT07301762
StatusENROLLING_BY_INVITATION
Start Date2025-11-24
Completion2026-12
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

The purpose of this research is to investigate whether enhancing systemic lymphatic drainage improves glymphatic function in patients with obstructive sleep apnea (OSA).

Frequently Asked Questions

What is Automated Manual Lymphatic Drainage Therapy to Improve Glymphatic Function in OSA Patients?

Automated Manual Lymphatic Drainage Therapy to Improve Glymphatic Function in OSA Patients is a clinical trial registered under NCT07301762. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07301762?

The current status of NCT07301762 (Automated Manual Lymphatic Drainage Therapy to Improve Glymphatic Function in OSA Patients) is: ENROLLING_BY_INVITATION.

When did Automated Manual Lymphatic Drainage Therapy to Improve Glymphatic Function in OSA Patients start?

Automated Manual Lymphatic Drainage Therapy to Improve Glymphatic Function in OSA Patients started on 2025-11-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑